Peter Pitts, a former associate commissioner of the FDA, joins "CUOMO" to discuss the resignation of Dr. Richard Pazdur, the ...

Rick Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his ...

So much for stability at the U.S. FDA. Three weeks after accepting the position as director of the FDA’s CDER, Richard Pazdur has informed the agency of his intention to retire at the end of the year.

A longtime FDA official who took over last month as the agency’s top drug regulator intends to retire.The departure of ...

Weeks after Dr. Rick Pazdur accepted the position as the U.S. Food and Drug Administration's top drug regulator, he announced his resignation.

The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...

Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...

Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug ...